Ioflubenzamide I-131

N/A

Report date: 2025/11/28 17:54:22
NME

Base Information

Drug NameIoflubenzamide I-131
Drug Alias Name131-I-MIP-1145MIP-1145BA-100Iodine-131 ZK-BAIodine-123 ZK-BA
ClassificationSmall moleculesDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[6] 
Mechanisms of ActionIonising radiation emitters
TargetsNot applicable
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Insight Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A